Financial statements Oz Pharma
Balance sheet data of OZ PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 513 061,52 | 567 251,19 | 708 035,67 | 736 249,74 | 839 388,62 | 954 307,97 |
| A. Fixed assets | 364 039,76 | 363 280,56 | 298 071,36 | 257 818,29 | 257 818,29 | 292 818,29 |
| B. Current assets | 149 021,76 | 203 970,63 | 409 964,31 | 478 431,45 | 581 570,33 | 661 489,68 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 513 061,52 | 567 251,19 | 708 035,67 | 736 249,74 | 839 388,62 | 954 307,97 |
| A. Equity | 471 984,66 | 523 468,51 | 596 606,11 | 693 458,40 | 812 610,88 | 925 742,75 |
| B. Liabilities and provisions for liabilities | 41 076,86 | 43 782,68 | 111 429,56 | 42 791,34 | 26 777,74 | 28 565,22 |
| I. Long-term liabilities | 0,00 | 0,00 | 82 900,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 41 076,86 | 43 782,68 | 28 529,56 | 42 791,34 | 26 777,74 | 28 565,22 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.